AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality ...

AngioDynamics, Inc. (NASDAQ:ANGO) is one of billionaire Steve Cohen’s small-cap stock picks with huge upside potential. On October 6, H.C. Wainwright reiterated its Buy rating on AngioDynamics (NASDAQ ...

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on AngioDynamics (ANGO – Research Report) today and set a price target of $14.00. Yi Chen has given his Buy rating due to a combination of ...

A month has gone by since the last earnings report for AngioDynamics (ANGO). Shares have lost about 3.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...

Medline Industries will purchase AngioDynamics’ fluid management portfolio for $167.5 million. The transaction will give Medline access to treatments to manage patient fluid levels and contrast media ...

Irving, Texas-based Novation has awarded an Innovative Technology Contract to AngioDynamics for its minimally invasive medical devices. AngioDynamics’ product offerings are medical devices for ...

AngioDynamics ANGO has been gaining from its solid prospects with NanoKnife and an increased focus on cancer treatment markets. The optimism, led by a solid fourth-quarter fiscal 2025 performance, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Latham-headquartered ...

A month has gone by since the last earnings report for AngioDynamics (ANGO). Shares have lost about 14.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...